Period of time： 2012年6期
Publisher： Adis International
Founded in： 2001
Total resources： 72
ISSN： 1175-3277
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
American Journal of Cardiovascular Drugs,volume 4,issue 6
Menu
By Adis International Limited in (2004)
American Journal of Cardiovascular Drugs,volume 4,issue 6 , Vol. 4, Iss. 6, 2004-01 , pp.
Access to resources
Recommend
By Nicholas L.M. Cruden, David E. Newby in (2004)
American Journal of Cardiovascular Drugs,volume 4,issue 6 , Vol. 4, Iss. 6, 2004-01 , pp.Paclitaxel-Eluting Stents: Current Clinical Experience
By Eberhard Grube, Lutz Buellesfeld in (2004)
American Journal of Cardiovascular Drugs,volume 4,issue 6 , Vol. 4, Iss. 6, 2004-01 , pp.Reversal of Left Ventricular Hypertrophy: What Have Recent Trials Taught Us?
By Paolo Verdecchia, Fabio Angeli in (2004)
American Journal of Cardiovascular Drugs,volume 4,issue 6 , Vol. 4, Iss. 6, 2004-01 , pp.Clinical and Experimental Experience with Factor Xa Inhibitors
By Juan F. Viles-Gonzalez, Juan Gaztanaga, Urooj M. Zafar, Valentin Fuster, Juan J. Badimon in (2004)
American Journal of Cardiovascular Drugs,volume 4,issue 6 , Vol. 4, Iss. 6, 2004-01 , pp.Intravascular Brachytherapy: Indications and Management of Adverse Events
American Journal of Cardiovascular Drugs,volume 4,issue 6 , Vol. 4, Iss. 6, 2004-01 , pp.By Katherine F. Croom, Gillian M. Keating in (2004)
American Journal of Cardiovascular Drugs,volume 4,issue 6 , Vol. 4, Iss. 6, 2004-01 , pp.Ezetimibe/Simvastatin: A Review of its Use in the Management of Hypercholesterolemia
By David Murdoch, Lesley J. Scott in (2004)
American Journal of Cardiovascular Drugs,volume 4,issue 6 , Vol. 4, Iss. 6, 2004-01 , pp.Cardiac Syndrome X: Diagnosis, Pathogenesis and Management
By Adis International Limited in (2004)
American Journal of Cardiovascular Drugs,volume 4,issue 6 , Vol. 4, Iss. 6, 2004-01 , pp.